Effect of preoperative transarterial chemoembolization on nephroblastoma

AIM: To explore the effect and mechanism of preoperative transarterial chemoembolization on nephroblastoma.METHODS: Comparative analysis of clinical and pathological features in 39 children with Wilms’ tumor was conducted.TUNEL assay was used to detect the apoptosis of tumor in two groups with or without preoperative interventional treatment.The expressions of P53,Bcl-2 and Bax proteins were detected by immunochemical methods.The patients were followed-up for more than 2 years.RESULTS: The extent of neoplastic cell necrosis and degeneration,interstital fiber tissue hyperplasia of tumor and the number of infiltrating lymphocytes were observed,which were higher in interventional group than those in simple excision group (P<0.01).The median of mitotic index in tumor cells was 0.2 in interventional group,and 1.4 in simple excision group.The median of apoptotic index (AI) of the tumor cells was 25.9 in study group and 12.8 in control group (Uc=54.50,P<0.01),(Uc=117.00,P<0.05).The comparison between the means obtained in two groups revealed statistical difference (P<0.05).The expressions of P53 and Bcl-2 proteins were not correlated with apoptotic index,but the rate of expression of Bax protein (80.0%) in interventional group was higher than that (40.0%) in simple excision group.The two year event-free rate was 73.3％ (11/15) in study group and 42.9％ (6/14) in control group.CONCLUSION: Transarterial chemoembolization on nephroblastoma is effectively used to kill and inhibit tumor cell growth,as well as induce tumor cell apoptosis by Bax protein.     

Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies

Antibodies can swiftly provide therapeutics to target disease-related molecules discovered in genomic research. Antibody engineering techniques have been actively developed and these technological innovations have intensified the development of therapeutic antibodies. From the mid-1990’s, a series of therapeutic antibodies were launched that are now being used in clinic. The disease areas that therapeutic antibodies can target have subsequently expanded, and antibodies are currently utilized as pharmaceuticals for cancer, inflammatory disease, organ transplantation, cardiovascular disease, infection, respiratory disease, ophthalmologic disease, and so on. This paper briefly describes the modes of action of therapeutic antibodies. Several non-clinical study results of the pathological changes induced by therapeutic antibodies are also presented to aid the future assessment of the toxic potential of an antibody developed as a therapeutic.     

Short-term baths with essential oils of Lippia sidoides,Ocimum gratissimum and Zingiber officinale influence blood parameters and survival of tambaqui (Colossoma macropomum) after infection with Aeromonas hydrophila

This study evaluated the effect of short-term baths with the essential oils (EOs) of Lippia sidoides, Ocimum gratissimum and Zingiber officinale on the survival, haematological, biochemical and histopathological parameters of native fish tambaqui (Colossoma macropomum), challenged with Aeromonas hydrophila. After challenge, the fish infected with A. hydrophila received therapeutic baths of 60 min, for five consecutive days. Treatments were as follows: challenged and not treated; challenged and treated with 10 mg L^?1 of gentamicin; challenged and treated with EO of L. sidoides (2.5 and 5.0 mg L^?1); challenged and treated with EO of O. gratissimum (5.0 and 10.0 mg L^?1); challenged and treated with Z. officinale EO (5.0 and 10.0 mg L^?1). The highest survival rates were 89.5% (fish treated with 5.0 mg L^?1 of O. gratissimum EO) and 75.0% (fish treated with 5.0 mg L^?1 of L. sidoides EO). Reductions in the haematocrit percentage, haemoglobin and erythrocyte number were observed in fish treated with L. sidoides and Z. officinale EOs compared with control fish. Mild to moderate damage to the liver tissue of fish after challenge and EO treatments were observed. It is suggested that baths containing O. gratissimum and L. sidoides EOs consist in a viable treatment to increase survival rates of C. macropomum infected with A. hydrophila.     

延胡索酸泰妙菌素对猪支原体肺炎的临床疗效实验

为了研究延胡索酸泰妙菌素对猪支原体肺炎的临床疗效,选用体重90 kg左右的2月龄健康杜洛克长白杂交猪,通过建立疾病模型和疗效评价指标判别延胡索酸泰妙菌素的治疗效果。结果表明,按1000 kg饲料添加100 g或200 g延胡索酸泰妙菌素,可以显著减轻感染猪的临床症状和病理变化,提高猪的增重,其效果优于磷酸泰乐菌素预混剂。     

单羰基姜黄素类似物对Ⅱ型糖尿病大鼠非酒精性脂肪肝的治疗作用研究

[目的]研究单羰基姜黄素类似物(代号B06)对Ⅱ型糖尿病大鼠非酒精性脂肪肝糖脂代谢紊乱的影响。[方法]应用高糖高脂饲料喂养,小剂量STZ干扰建立Ⅱ型糖尿病大鼠模型[1],并随机分模型组、A75治疗组、C66治疗组、正常对照组,各组均灌胃治疗12周;检测各组大鼠血生化指标[2]。[结果]单羰基姜黄素类似物能明显改善试验性Ⅱ型糖尿病大鼠的血糖升高,FINS明显低于模型组;肝脏TC、血清TG、TC有明显的降低作用,对血清HDL有明显的升高作用,有统计学意义;[结论]单羰基姜黄素类似物对Ⅱ型糖尿病大鼠非酒精性脂肪肝有一定的治疗作用。     

Clinical Therapeutic Effect of Praziquantel Injection on Buffalo Schistosomiasis

To observe the clinical therapeutic effect of 30% praziquantel injection on buffalo schistosomiasis, the sick buffalos naturally infected with Schistosoma japonicum were selected by miracidium hatching method. In experimental clinical trials, sick buffalos were randomly divided into five groups, high-dose (20 mg/kg), middle-dose (10 mg/kg) and low-dose (5 mg/kg) praziquantel injection groups, praziquantel tablet group (30 mg/kg) and positive control group. After the treatment of 30 d, the negative conversion rate of miracidium were 100.0%, 100.0%, 77.8% and 85.7%, respectively, in praziquantel injection groups with the high, middle and low dose and oral medication group. In expanded clinical trials, the sick buffalos were randomly divided into two groups, praziquantel injection group (10 mg/kg, i.m.) and praziquantel tablet group (30 mg/kg). The results showed that, the negative conversion rate of miracidium were all 100% in the former 52 patients and the latter 6 patients after 30 d. The research confirmed that praziquantel injection was significantly effective in the treatment of buffalo schistosomiasis and convenient for administration. It was concluded that 30% praziquantel injection could replace the traditional oral praziquantel tablet for the treatment of buffalo schistosomiasis, and the recommended dose was 10 mg/kg.     

骨质疏松症治疗药物的研究进展

骨质疏松症是以骨量减少、骨的微观结构退化为特征,致使骨的脆性增加并易于发生骨折的一种全身性骨骼疾病,是当前严重危害人类特别是绝经妇女和老人的疾病之一.近年来出现了许多预防和治疗骨质疏松症的药物,极大地推动了骨质疏松症理论基础的完善和临床治疗研究.就该领域的研究进展进行了简要综述.     

Evaluation using hoof wall strain gauges of a therapeutic shoe and a hoof cast with a heel wedge as potential supportive therapy for horses with laminitis

OBJECTIVE: To evaluate using strain gauges, a hoof cast with heel wedge, and a therapeutic shoe with unsupported toe for their effectiveness in redistribution of load from the dorsal hoof wall. STUDY DESIGN: In vitro biomechanical study. SAMPLE POPULATION: Twenty forelimb specimens. METHODS: Rosette strain gauges were placed on the dorsal and lateral hoof wall of 20 normal shaped hooves. Limbs were loaded vertically using a tensile testing machine with a 1 Hz sinusoidally cycling load up to 3000 N during 15 seconds. Mean values of principal strain and direction at 2500 N load were calculated for 3 experimental conditions (unshod, therapeutic shoe with unsupported toe, and hoof cast with heel elevation) and tested by ANOVA (P<.05). RESULTS: Vertical limb loading in an unshod hoof leads to a biaxial compression of the dorsal wall with high longitudinal compression (epsilon2 = -1515 microm/m). Principal strain at the dorsal wall (epsilon2) was decreased by 23% with the therapeutic shoe and by 59% with the hoof cast. On the lateral hoof wall principal strain was unchanged with the shoe, but increased by 34% with the cast. CONCLUSIONS: Strain measurements indicate unloading of the dorsal hoof wall by both methods with the cast being more effective than the shoe. CLINICAL RELEVANCE: The hoof cast with wedge offers substantial unloading of the dorsal wall, but increases load on the quarter. Therefore a hoof cast would likely be most helpful in acute laminitis when palmar structures can still bear load. The therapeutic shoe offers rehabilitation and regrowth of the dorsal wall without increased load on the quarter wall.     

犬贫血性疾病输血疗法的疗效观察

输血疗法是救治动物的一项重要措施。为了验证输血疗法的作用,对数十例贫血病病犬进行输血疗法治疗,通过血常规检查、血液生化学检查等发现患犬均患有不同程度的贫血,红细胞数、血红蛋白含量、红细胞压积均明显低于正常值,在治疗原发病的同时配合了输血疗法。经过一段时间的治疗,发现应用输血疗法治疗的患犬痊愈快,患犬的红细胞数、血红蛋白含量、红细胞压积均逐渐升高接近正常值。由此可见,输血疗法对犬贫血病的治疗效果较好。     

金丝桃素粉剂对人工感染传染性囊病病毒鸡的疗效试验

金丝桃素是从贯叶连翘中提取的一种极具抗病毒活性成分。为了研究金丝桃素粉剂对腔上囊的治疗效果,对20日龄雏鸡人工感染传染性囊病病毒(IBDV BC-6/85)后,以不同的剂量连续4d口服金丝桃素粉剂。通过观察腔上囊和肌肉的出血情况,以及病原分离,评价该药物对鸡传染性囊病的治疗效果。结果表明:以667.9mg/kg体重的金丝桃素粉剂连续口服给药4d,能有效的治疗传染性囊病,效果优于对照药物高免卵黄抗体。